$78.24
-0.28-0.36%
Pre-Market: 8:20 AM EDT
15 minutes delayed
Comments
Loading...
AstraZeneca
AZNNASDAQ
Latest news for AstraZeneca (NASDAQ:AZN) Stock
AstraZeneca Stock (NASDAQ: AZN)
Categories: All
Friday, July 26, 2024
Thursday, July 25, 2024
- FDA Advisory Committee Reviewed Imfinzi For R...
- Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
- AstraZeneca shares are trading lower after th...
- AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines
- CORRECTION: AstraZeneca Q2 Adj. EPS $1.98 Inl...
- Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
- Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
- American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday
- AstraZeneca Raised Its 2024 Guidance: Now Exp...
Tuesday, July 23, 2024
Monday, July 22, 2024
Sunday, July 21, 2024
Thursday, July 18, 2024
Wednesday, July 17, 2024
Friday, July 12, 2024
Friday, July 05, 2024
Tuesday, July 02, 2024
Monday, July 01, 2024
Thursday, June 27, 2024
Wednesday, June 26, 2024
Tuesday, June 25, 2024
Monday, June 24, 2024
Friday, June 21, 2024
Tuesday, June 18, 2024
Monday, June 17, 2024
- What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
- FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer
- AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer
- Reports Sunday, AstraZeneca Reports 27% Decre...